SHARK MONEYYACHT CLUBSearch Shark Money
Search public and private companies, people, funds, markets, tools, and research.
Venture capital database
Company creation · Incubation · Seed · Early stage
Atlas Venture
Cambridge, Massachusetts, US
Atlas Venture focuses on Biotechnology, Therapeutics, Life sciences across company creation through incubation through seed through early stage. Team and company relationships are indexed from official firm pages.
Strategy lens
Declared focus vs. observed sample
Declared focus reflects the firm’s own strategy language. Observed sectors summarize only the source-linked companies currently indexed here; it is not the firm’s complete portfolio allocation.
agonist-antibody therapeutics1
bispecific therapeutics for inflammatory disease1
kidney-targeted oligonucleotide medicines1
large-gene-delivery therapeutics1
precision medicines1
preeclampsia therapeutics1
Founder fit screen
Prepare before contacting Atlas
Use the firm’s declared strategy and sourced relationship graph to build a specific outreach thesis. This is a preparation framework—not a claim about current appetite or check size.
Stage fit
Explain why the company belongs in Company creation, Incubation, Seed and what proof has already removed the prior stage’s risk.
Sector fit
Anchor the opportunity to Biotechnology, Therapeutics, Life sciences. Name the specific market shift and why it is happening now.
Partner fit
Review 2 indexed team profiles. Address the partner whose operating history and portfolio context best match the company.
Portfolio context
Study the 6 source-linked companies shown here. State whether the company is complementary, differentiated, or potentially competitive.
Evidence packet
Bring customer proof, cohort or deployment metrics, gross-margin logic, capital use, key risks, and the milestone this financing should unlock.
Contact route
Use the firm’s public route and keep the request precise: company, stage, round, traction, why this firm, and one clear next step.
Key people
Official team source Who shapes the partnership
Partner
Bruce Booth, D.Phil.
Partner at Atlas Venture, working in a firm focused on Biotechnology, Therapeutics, Life sciences.Partner
Jean-François Formela, M.D.
Partner at Atlas Venture, working in a firm focused on Biotechnology, Therapeutics, Life sciences. Selected relationships
Official portfolio source Investments listed by the firm
large-gene-delivery therapeutics
Official sourceAAVantgarde Bio
Open the company graph to see founders and every indexed investor relationship.
precision medicines
Official sourceAntares Therapeutics
Open the company graph to see founders and every indexed investor relationship.
bispecific therapeutics for inflammatory disease
Official sourceCaldera Therapeutics
Open the company graph to see founders and every indexed investor relationship.
preeclampsia therapeutics
Official sourceComanche Biopharma
Open the company graph to see founders and every indexed investor relationship.
agonist-antibody therapeutics
Official sourceDiagonal Therapeutics
Open the company graph to see founders and every indexed investor relationship.
kidney-targeted oligonucleotide medicines
Official sourceJudo Bio
Open the company graph to see founders and every indexed investor relationship.
Help complete the graphClaim or improve
Claim or improve
Atlas Venture.
Founders, firm teams, investors, and careful researchers can submit a missing fact or correction. Every change enters a review queue and requires public evidence.
- No unsourced edits
- Identity and scope reviewed
- Existing claims retain history
Source discipline
This dossier uses publicly available firm pages for team, strategy, and portfolio context. It does not infer check size, ownership, valuation, current holding status, or availability for introductions.